Balancing Communal Goods and Personal Privacy Under a National Health Informational Privacy Rule by Gostin, Lawrence O. et al.
Saint Louis University Law Journal 
Volume 46 
Number 1 (Winter 2002) Article 4 
2-12-2002 
Balancing Communal Goods and Personal Privacy Under a 
National Health Informational Privacy Rule 
Lawrence O. Gostin 
Georgetown University Law Center 
James G. Hodge Jr. 
Johns Hopkins School of Public Health 
Mira S. Burghardt 
Follow this and additional works at: https://scholarship.law.slu.edu/lj 
 Part of the Law Commons 
Recommended Citation 
Lawrence O. Gostin, James G. Hodge Jr. & Mira S. Burghardt, Balancing Communal Goods and Personal 
Privacy Under a National Health Informational Privacy Rule, 46 St. Louis U. L.J. (2002). 
Available at: https://scholarship.law.slu.edu/lj/vol46/iss1/4 
This Symposium is brought to you for free and open access by Scholarship Commons. It has been accepted for 
inclusion in Saint Louis University Law Journal by an authorized editor of Scholarship Commons. For more 
information, please contact Susie Lee. 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
 
5 
BALANCING COMMUNAL GOODS AND PERSONAL PRIVACY 
UNDER A NATIONAL HEALTH INFORMATIONAL PRIVACY RULE 
LAWRENCE O. GOSTIN*, JAMES G. HODGE, JR.**  
AND MIRA S. BURGHARDT*** 
Every single health care professional, every insurance agent, every researcher, 
every member of an IRB, every public health official, every pharmacist . . .  – 
every single person who comes in contact with health care records must 
understand why its important to keep them safe, how they can keep them safe, 
[and] what will happen to them if they do not keep them safe.1 
INTRODUCTION 
On April 14, 2001, President George W. Bush approved the Standards for 
Privacy of Individually Identifiable Health Information (hereinafter referred to 
as “health data privacy rule”).  These regulations, which represent the first 
systematic national privacy protections of health information,2 flow from a 
Congressional mandate in the Health Insurance Portability and Accountability 
Act of 1996 (HIPAA).3  HIPAA required that health information privacy 
protections be implemented either through federal legislation or administrative 
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Georgetown and Johns Hopkins Universities.  The authors would like to acknowledge the 
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 1. Donna E. Shalala, Health Care Information and Privacy, 8 HEALTH MATRIX 223, 231 
(1998) (emphasis added). 
 2. See Press Release, President George W. Bush (Apr. 12, 2001), available at 
http://www.whitehouse.gov/news/releases/2001/04/20010412-1.html (last visited Oct. 19, 2001); 
Press Release, Secretary Tommy G. Thompson, Statement by HHS Secretary Tommy G. 
Thompson Regarding the Patient Privacy Rule (Apr. 12, 2001), available at 
http://www.hhs.gov/news/press/2001pres/20010412.html (last visited Jan. 7, 2001) [hereinafter 
Press Release, Secretary Thompson]. 
 3. Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-191, 110 
Stat. 1936 (1996) [hereinafter HIPAA]. 
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regulation by the Department of Health and Human Services (HHS).  The 
regulations protect the privacy of individually-identifiable health records in 
any form (including electronic, paper and oral) through disclosure and use 
limitations, fair information practices, and privacy and security policies that 
apply to “covered entities” (meaning health providers, health insurance plans 
and health care clearinghouses) and their business associates. 
Privacy safeguards are needed because of the personal nature of health data 
and the rapid shift from paper to electronic records.  The harms of 
unauthorized disclosures of health information are well rehearsed.  Health 
information used by health providers, insurers and data processors can include 
intimate details about the patient’s mental and physical health as well as social 
behaviors, personal relationships and financial status.4  Unwarranted 
disclosures of this information may lead to societal stigmatization and 
discrimination.  Unauthorized disclosures can also lead to a loss of patient trust 
in medical providers, resulting in a reluctance to seek medical treatment for 
some conditions or failure to disclose important information to health 
professionals.5 
Privacy concerns are compounded by the shift from paper-based to 
electronic medical record-keeping in the past two decades.  Health information 
is increasingly accessed, used, disclosed and stored in electronic format.  This 
does not necessarily mean health data are less secure, as electronic systems are 
in many ways safer than manual systems.  Nevertheless, electronic data can be 
accessed in greater quantities and manipulated in ways that are virtually 
impossible for manual systems.  Thus, while significant benefits may flow 
from the electronic health information infrastructure, the potential to disclose 
or reveal sensitive health data has raised individual fears of privacy violations.  
In one recent survey, over 80% of the public respondents felt they had “lost all 
control” over their personal information.6 
Patients concerned about a lack of privacy were unlikely to be comforted 
by federal protections before the promulgation of the HIPAA rule.  Prior to the 
rule, there had never been systematic national health information protection.  
While most states have privacy safeguards, they are so variable and incoherent 
that they are widely regarded as inadequate.  Congress’s grant of authority to 
HHS to develop privacy standards offered the promise of a considered and 
comprehensive regulatory solution to address the concerns of consumers and 
privacy advocates.  The standards endeavor to protect patient privacy by 
limiting disclosures of individually-identifiable medical information (or 
 
 4. See Lawrence O. Gostin, Health Information Privacy, 80 CORNELL L. REV. 451, 490 
(1995) [hereinafter Gostin, Health Information Privacy]. 
 5. See id. at 490-91. 
 6. Id. at 454.  See also Harris Equifax, Health Information Privacy Survey (1993), available 
at http://www.epic.org/privacy/medical/polls.html (last visited Oct. 19, 2001). 
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“protected health information”(PHI)).  Disclosure and use of PHI can only 
occur upon patient consent.  The regulations also implement fair information 
practices, which have long been a feature of existing federal laws.7  Fair 
information practices allow patients to (1) inspect and amend their records, (2) 
receive notice of covered entities’ privacy practices and potential uses and 
disclosures of health information, and (3) request confidential communications 
and an accounting of actual disclosures. 
Through the regulations, HHS attempts to protect individual privacy while 
recognizing legitimate needs for such data to process health claims and deliver 
medical care as well as provide for communal goods (including public health 
and health research).  Concerning uses and disclosures of health data, HHS 
carves out several important exceptions to the consent requirements: 
1) Law enforcement.  Law enforcement officials may receive information 
from covered entities without consent pursuant to a court order, subpoena or 
other legal order. 
2) Judicial and administrative proceedings.  A covered entity may disclose 
PHI in a judicial or administrative proceeding without the individual’s consent 
in response to an order of the court or administrative tribunal or in certain 
circumstances, a subpoena or discovery request. 
3) Commercial marketing.  Covered entities may use or disclose personal 
health information for face-to-face commercial marketing to individuals or 
regarding products or services of nominal value. 
4) Parents of unemancipated minors.  Parents are recognized as personal 
representatives of unemancipated minors.  While the rule places certain 
restrictions on parent’s access to the child’s medical record, HHS 
acknowledges that the Bush Administration is likely to relax those limitations.8 
5) Family members, friends, and caretakers (“significant others”) of adults 
and emancipated minors.  Covered entities may disclose limited health 
information of an adult or emancipated minor without consent to a relative, 
personal friend or designated person in the case of an emergency or in the 
course of basic care-taking duties. 
6) Public health.  PHI can be disclosed for numerous public health 
purposes without consent, including to (a) prevent or control disease, injury or 
disability, (b) report child abuse or neglect, (c) report relevant information to 
the Food and Drug Administration, and (d) report to an employer conducting 
medical surveillance in the workplace if the employee is notified. 
7) Health research.  A covered entity can use or disclose PHI for research 
without consent if it obtains a waiver from an Institutional Review Board 
(IRB) or a privacy board according to a series of considerations.9 
 
 7. See infra Part II.D. for a discussion of fair information practices. 
 8. See Press Release, Secretary Thompson, supra note 2. 
 9. See generally 45 C.F.R. § 164.512 (2001). 
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Many of these provisions leave significant gaps in privacy protection.  
HHS admits that the rule only sets a “floor” of protection that “balance[s] the 
needs of the individual with the needs of society.”10  However, the rule 
contains many flaws as a base-line standard, promoting inappropriate trade-
offs between the public welfare and individual privacy.  The rule inadequately 
protects privacy in certain contexts, including the consent requirements for use 
and disclosure of PHI for health care purposes and some fair information 
practices provisions.  In contrast, the rule sometimes fails to assure that 
information can be used when necessary for significant communal benefits or 
requires substantial burdens on the health care industry without providing 
meaningful protection for patients. 
In Part I, we examine how the threat to personal privacy from the 
developing electronic health information infrastructure necessitates 
comprehensive national health information privacy regulations.  Attempts by 
federal and state officials to regulate the use and disclosure of personal health 
information prior to the new standard have been inadequate because existing 
legal provisions allow multiple exceptions to privacy prohibitions. 
We examine and analyze the framework of HHS’s effort to protect 
individually identifiable electronic health information in Part II.  Patients 
obtain several new rights and protections related to their individually 
identifiable health information.  However, throughout the standard, 
inappropriate trade-offs between individual privacy and communal goods 
compromise the strides made for protecting personal health information 
privacy.  A brief conclusion follows. 
I.  THE ELECTRONIC HEALTH INFORMATION INFRASTRUCTURE AND PERSONAL 
PRIVACY 
A. Health Data in the Electronic Health Information Infrastructure 
Protecting the privacy of identifiable health information was one of the key 
priorities of Congress in enacting the Health Insurance Portability and 
Accountability Act of 1996.  One of the main reasons that Congress desired 
privacy protection was its concern about the proliferation of electronic health 
information.  During the mid-1980’s, fundamental shifts in the organization, 
delivery and financing of health care services led to the development of more 
 
 10. Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg. 
82,462 (Dec. 28, 2000).  For electronic copies of the health data privacy rule, including the 
background materials and comments published in the federal register, see the Department of 
Health and Human Services’ website, available at http://aspe.hhs.gov/admnsimp (last visited Jan. 
7, 2002) or http://www.hhs.gov/ocr/hipaa (last visited Jan. 7, 2002). 
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sophisticated health information systems.11  Today, individual patient medical 
records are increasingly stored in electronic databases by government and 
private medical providers.  The goal that fueled these changes, as expressed by 
the Institute of Medicine and others, was that patient medical records should be 
recorded in every health care setting and accessed widely among health care 
professionals.12  These changes are transforming how health information is 
acquired, used, disclosed and stored in the modern health care system. 
Many advantages exist to the systemic collection and use of electronic 
health data.  More accurate and accessible data allow consumers to make more 
informed decisions about health plans, providers, diagnoses, products and 
treatments.  Clinical care is improved through faster and more accurate 
diagnoses,13 increased checks on medical procedures,14 prevention of adverse 
drug events15 and the dissemination of expert medical information in areas 
traditionally under-served through telemedicine and other techniques.  Medical 
research on the causes of disease and injuries and health services research 
concerning the quality and cost-effectiveness of health care services are 
improved through increased access to information and more accurate 
information.  Public health surveillance of injuries and diseases in the 
population is facilitated.16  Finally, electronic security tools including personal 
access codes, encryption programs17 and audit trails18 can more efficiently 
monitor health care fraud and abuse19 and protect data from unauthorized uses 
and disclosures. 
Along with these benefits, however, come significant costs.  The 
computerization of health data raises significant privacy concerns.  Health care 
 
 11. See NATIONAL RESEARCH COUNCIL, COMMITTEE ON MAINTAINING PRIVACY AND 
SECURITY IN HEALTH CARE APPLICATIONS OF THE NATIONAL INFORMATION INFRASTRUCTURE, 
FOR THE RECORD: PROTECTING ELECTRONIC HEALTH INFORMATION 21-22 (1997); Lawrence O. 
Gostin, Personal Privacy in the Health Care System: Employer-Sponsored Insurance, Managed 
Care, and Integrated Delivery Systems, 7 KENNEDY INST.  ETHICS J. 361, 364 (1997). 
 12. See Gostin, Health Information Privacy, supra note 4, at 452-53. 
 13. See Dereck L. Hunt et al., Effects of Computer-Based Clinical Decision Support Systems 
on Physician Performance and Patient Outcomes, 280 JAMA 1339, 1342 (1998). 
 14. See David W. Bates et al., Effect of Computerized Physician Order Entry and a Team 
Intervention on Prevention of Serious Medication Errors, 280 JAMA 1311, 1315 (1998). 
 15. See Robert A. Raschke et al., A Computer Alert System to Prevent Injury from Adverse 
Drug Events, 280 JAMA 1317, 1320 (1998). 
 16. See Lawrence O. Gostin et al., The Public Health Information Infrastructure, 275 JAMA 
1921, 1921 (1996) [hereinafter Gostin et al., Genetic Privacy and the Law].  See also Antoine 
Flahault et al., FluNet as a Tool for Global Monitoring of Influenza on the Web, 280 JAMA 1330 
(1998). 
 17. See Elizabeth Corcoran, Breakthrough Possible in Battle over Encryption Technology, 
WASH. POST, July 12, 1998, at A8. 
 18. See NATIONAL RESEARCH COUNCIL, COMPUTERS AT RISK: SAFE COMPUTING IN THE 
INFORMATION AGE 88 (1991). 
 19. See Gostin, Health Information Privacy, supra note 4, at 481. 
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data about individuals are among the most sensitive types of personal 
information.  These records contain large amounts of personal information 
which can be used to create a profile of an individual, including 1) 
demographic information, such as age, sex, race, marital status, children and 
occupation; 2) financial information, such as employment status, income and 
methods of payment; 3) medical information about diagnoses, treatments, 
disabilities, end-of-life decisions and disease histories of the individual and 
family members; 4) genomic information, such as diagnostic tests for carrier 
traits and genetically-related diseases; 5) personal identifiers other than name, 
including Social Security number, addresses and phone numbers; and 6) 
information about why treatment is sought, such as being the victim of a 
violent crime, firearm injury or the at-fault party in an auto accident.20 
In a society which strongly values individual autonomy and decision-
making, protecting the privacy of personally-identifiable health data is critical.  
Insufficient protections of health care information lead to unauthorized 
disclosures which may subject individuals to social stigma and discrimination 
by insurance companies, health care professionals and institutions, and 
employers.21  Patients have a reasonable expectation of privacy in their 
personal affairs provided the exercise of these interests does not harm others.22  
Respecting personal privacy requires that individuals maintain some degree of 
control over their personal information.  In addition, protecting the privacy of 
individually-identifiable health information is often important to achieve 
benefits to the population, such as public health surveillance and longitudinal 
health research.  As we (and others) have stated, protecting health information 
privacy (for instance, by providing individuals some control over their health 
data without severely restricting warranted uses of the data) directly improves 
the quality of health care and public health data (for instance, by encouraging 
individuals to fully utilize health services and cooperate with health 
agencies).23 
 
 20. See Lawrence Gostin, Health Care Information and the Protection of Personal Privacy: 
Ethical and Legal Considerations, 127 ANNALS INTERNAL MED. 683, 684-85 (1997). 
 21. See, e.g., Lawrence O. Gostin & James G. Hodge, Jr., The “Names Debate”: The Case 
for National HIV Reporting in the United States, 61 ALB. L. REV. 679, 724 (1998). 
 22. TOM L. BEAUCHAMP & JAMES F. CHILDRESS, PRINCIPLES OF BIOMEDICAL ETHICS 126 
(4th ed. 1994). 
 23. James G. Hodge, Jr. et al., Legal Issues Concerning Electronic Health Information, 282 
JAMA 1466, 1470 (1999). 
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B. The Inadequacy of Existing Legal Protections 
Personal privacy can be safeguarded in several ways, including through the 
privacy policies of data holders in the public and private sectors.24  The law, 
however, is uniquely important because it sets clear standards that are 
enforceable through courts and administrative bodies.  Legal safeguards may 
be expressed through federal or state constitutional protections of health 
information privacy, legislation or case law.  Despite the law’s potential to 
protect privacy, existing legal safeguards are inadequate, fragmented and 
inconsistent.  There exist major gaps in legal protection of privacy and 
significant theoretical problems with the structure of privacy protection. 
1. Constitutional Right to Privacy 
The Supreme Court has not articulated a clear, strong standard for a 
constitutional right to informational privacy outside the Fourth Amendment.25  
Judicial recognition of a constitutional right to informational privacy is 
particularly important because the government is a primary collector and 
disseminator of health information.  A constitutional right would help shield 
individuals from unauthorized government acquisition or disclosure of 
personal information. 
The Constitution does not expressly provide a right to informational 
privacy.26  The judiciary, however, has recognized a limited right to 
informational privacy as a liberty interest within the Fifth and Fourteenth 
Amendments.  In Whalen v. Roe,27 the United States Supreme Court examined 
 
 24. The law is merely one tool to improve individual privacy protections.  Internal privacy 
policies of health care providers, data processors and other private sector entities, which acquire, 
use and disclose identifiable health data can greatly impact individual expectations of the privacy 
of their health information.  The same can be said for voluntarily-executed policies of 
governmental holders of data, including public health agencies, researchers, universities and 
academic centers, and other commissions or agencies.  Adherence to ethical principles and human 
rights documents in support of the privacy of individual health data may also lead to greater 
privacy protections.  Ultimately, however, where government and the private sector fail to 
administer sufficient privacy protections, the law may guide, if not require, such protections. 
 25. See generally, Seth F. Kreimer, Sunlight, Secrets, and Scarlet Letters: The Tension 
Between Privacy and Disclosure in Constitutional Law, 140 U. PA. L. REV. 1 (1991); Richard C. 
Turkington, Legacy of the Warren and Brandeis Article: The Emerging Unencumbered 
Constitutional Right to Informational Privacy, 10 N. ILL. U. L. REV. 479 (1990); Francis S. 
Chlapowski, Note, The Constitutional Protection of Informational Privacy, 71 B.U. L. REV. 133 
(1991). 
 26. See Gostin, Health Information Privacy, supra note 4, at 495. 
 27. 429 U.S. 589 (1977); see also Nixon v. Adm’r of Gen. Servs., 433 U.S. 425, 465 (1977).  
In Nixon, the court held that while the President has 
a legitimate expectation of privacy in his personal communications . . . the 
constitutionality of the Act must be viewed in the context of the limited intrusion of the 
screening process, of appellant’s status as a public figure, of his lack of any expectation of 
privacy in the overwhelming majority of the materials, of the important public interest in 
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whether the constitutional right to privacy encompasses the collection, storage 
and dissemination of health information in government data banks 
(specifically, a New York public health database containing pharmaceutical 
records).  While the Court acknowledged a “threat to privacy implicit in the 
accumulation of vast amounts of personal information in computerized data 
banks or other massive government files,”28 it failed to tailor a constitutional 
remedy to meet this threat.  Justice Stevens, writing for a unanimous Court, 
simply recognized that “in some circumstances” the duty to avoid unwarranted 
disclosures “arguably has its roots in the Constitution.”29  Provided the state 
has adequate standards and procedures for protecting the privacy of sensitive 
medical information, the Court found no privacy violation.30  Whalen has been 
subsequently interpreted as affording a tightly circumscribed right to 
informational privacy. 
In general, courts have employed a flexible test balancing the government 
invasion of privacy against the strength of the government interest.31  Where 
the government can articulate a valid societal purpose and employs reasonable 
security measures, traditional governmental activities of information collection 
are deemed not to infringe upon constitutional informational privacy rights.  
Any right to privacy under the federal or state constitutions32 is, of course, 
limited to state action.  Thus, collection and use of health data by private or 
quasi-private health data organizations, health plans researchers and insurers is 
constitutionally unprotected. 
 
the preservation of the material, and of the virtual impossibility of segregating the small 
quantity of private materials without comprehensive screening . . . the appellant’s privacy 
claim is without merit. 
Id. 
 28. Whalen, 429 U.S. at 605. 
 29. Id. 
 30. Id. 
 31. For example, the court in United States v. Westinghouse Electric Corp. held that the 
National Institute of Occupational Safety and Health was entitled to receive the medical records 
of private employees exposed to toxic substance, subject to their informed consent.  638 F.2d 
570, 578 (3d Cir. 1980).  The court enunciated five factors to be balanced in determining the 
scope of the constitutional right to informational privacy: (1) the type of record and the 
information it contains, (2) the potential for harm in any unauthorized disclosure, (3) “the injury 
from disclosure to the relationship in which the record was generated,” (4) “the adequacy of 
safeguards to prevent unauthorized disclosure,” and (5) “the degree of need for access”—
meaning, a recognizable public interest.  Id. 
 32. See, e.g., Rasmussen v. S. Fla. Blood Serv., Inc., 500 So. 2d 533 (Fla. 1987).  Since the 
1970s, more than a dozen states have adopted constitutional amendments designed to protect a 
variety of privacy interests, including limitations on access to personal information.  See Gostin, 
Health Information Privacy, supra note 4, at 498. 
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2. Common Law Protections 
Most states recognize via common and statutory law the legal duties of 
confidentiality of certain health care professionals (including physicians, 
nurses and lab technicians) not to disclose health information.  Yet, these 
duties are not absolute: “Disclosures without individual consent may lawfully 
be made to [1] protect third parties from identifiable harm, [2] to report 
information for public health purposes as required by state law, or [3] 
sometimes in cases of medical emergency.  Unwarranted disclosures, however, 
may subject responsible parties to civil liability . . . .”33 
Although a traditional construct of privacy protections and a forerunner of 
modern privacy theory, the duty of confidentiality is antiquated.  
Confidentiality is predicated on the existence of a physician/patient 
relationship.  However, modern data collection is based only in small part on 
this relationship.  Health records contain a substantial amount of information 
gathered from numerous primary and secondary sources: laboratories, 
pharmacies, schools, public health officials, researchers, insurers and other 
individuals and institutions.  Paper or electronic patient health records are not 
merely kept in the office of private physicians or health plans, but also by 
government agencies, regional health database organizations and information 
brokers.  The duty of confidentiality arising at the point of clinical care or 
research simply does not convey a right to confidentiality in all these important 
contexts. 
3. Existing Legislative and Administrative Protections 
Federal and state legislatures and executive agencies have enacted and 
considered a growing number of statutes and regulations to protect privacy.34  
The federal government has previously enacted several statutes and regulations 
to protect privacy of health information.  The Privacy Act of 197435 requires 
federal agencies to utilize fair information practices regarding the collection, 
use or dissemination of systematized records, including health data.  The 
Freedom of Information Act (FOIA) of 196636 requires the federal government 
to disseminate various information but exempts several categories of records, 
including personally-identifiable health information.  Other federal regulations 
protect health information privacy relating to the treatment of persons for drug 
 
 33. Lawrence O. Gostin & James G. Hodge, Jr., Genetic Privacy and the Law: An End to 
Genetics Exceptionalism, 40 JURIMETRICS 21, 46 (1999) [hereinafter Gostin & Hodge, Genetic 
Privacy and the Law].  See also McCormick v. England, 494 S.E.2d 431, 439 (S.C. Ct. App. 
1997); Gostin, Health Information Privacy, supra note 4, at 508-11. 
 34. For a discussion of various regulations enacted to protect privacy, see Gostin, Health 
Information Privacy, supra note 4, at 499-508. 
 35. 5 U.S.C. § 552a (2000). 
 36. 5 U.S.C. § 552 (b)(1)-(3) & (6) (1988). 
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or alcohol dependency in federally-funded facilities37 and the administration of 
human subject research.38 
Most states have passed privacy statutes that mimic the Federal Privacy 
Act39 and FOIA,40 and thus apply only to state collections of data.  A few states 
have enacted comprehensive medical information privacy acts.41  These laws 
provide broad protections of health information acquired, collected, used or 
disclosed within the state.  States have also passed disease-specific privacy 
laws which set forth stringent privacy and security protections for certain types 
of information, including medical information concerning one’s HIV status42 
or other sexually-transmitted diseases,43 genetic information,44 information 
utilized in medical research (such as state cancer registries) or public health 
information.45 
Though existing federal and state privacy statutes and regulations are 
meaningful and serve valuable ends, they share several weaknesses: (1) like 
constitutional privacy protections, most statutes apply primarily to government 
collections, uses or disclosures of health information, and thus often do not 
confer protections to health information in the private sector; (2) they fail to 
address the new challenges to individual privacy arising from the automation 
of medical records; (3) they collectively represent a patchwork effort to 
address the privacy and security of specific health information or information 
held by specific entities, and thus do not comprehensively protect health 
information; (4) some kinds of data are treated as super-confidential (for 
instance, HIV/AIDS), while other data are virtually unprotected, leading to 
inconsistencies and unfairness; (5) they do not effectively balance competing 
individual interests in privacy with the need to use the data for the common 
good; and (6) some state laws prohibit disclosures without informed consent, 
but list so many exceptions as to swallow the rule.  These weaknesses in 
existing law require a national approach to privacy protection.  The health data 
privacy rule provides such a national standard and makes significant strides in 
protecting health data.  However, the rule shares many of the weaknesses of 
existing privacy laws.  In some ways, the rule inadequately protects privacy, 
 
 37. 42 U.S.C. § 290dd-2 (Supp. V 1994). 
 38. 45 C.F.R. § 46.111(7) (1993). 
 39. See, e.g., N.Y. PUB. OFF. LAW §§ 91-99 (McKinney 2001). 
 40. See, e.g., MISS. CODE ANN. §§ 25-61-1 (1972). 
 41. See, e.g., CAL. CIV. CODE §§ 56-56.35 (West 1982 & Supp. 2001); WASH. REV. CODE 
ANN. §§ 70.02.005-70.02.904 (West 1992 & Supp. 2001). 
 42. See generally Harold Edgar & Hazel Sandomire, Medical Privacy Issues in the Age of 
AIDS: Legislative Options, 16 AM. J.L. & MED. 155 (1990) (examining state legislation dealing 
with HIV related problems in medical privacy laws). 
 43. See Lawrence O. Gostin, The Future of Public Health Law, 12 AM. J.L. & MED. 461, 
486 (1986). 
 44. See, e.g., Gostin & Hodge, Genetic Privacy and the Law, supra note 33, at 47. 
 45. See Gostin et al., Genetic Privacy and the Law, supra note 16, at 1922. 
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while in other ways it fails to assure that data are shared where necessary to 
protect the public’s welfare. 
II.  PROTECTING PERSONAL PRIVACY IN THE NEW STANDARD 
The creation of a national health information privacy rule might seem 
uncontroversial in light of existing public apprehensions, current gaps in legal 
protections and Congress’s commitment to better protecting such data.  
However, the health privacy rule was established only after years of struggle 
and efforts in the legislative and executive branches.  In HIPAA, Congress 
created a self-imposed deadline of August 21, 1999 to pass health information 
privacy legislation.46  Due in part to the lobbying of the various interest groups 
affected by such legislation,47 Congress failed to reach a consensus by the 
deadline.48  In default, HIPAA authorized the Secretary of the HHS to issue 
privacy regulations if Congress failed to meet the deadline.49  After issuing a 
proposed rule in November, 1999,50 HHS received over 50,000 public 
comments.51  The final rule was promulgated in December, 2000 at the end of 
President Clinton’s term.52  Reflecting President Bush’s promise to reassess 
regulations enacted late in his predecessor’s term,53 the comment period was 
re-opened and HHS received several thousand additional comments.54  Though 
privacy advocates were concerned that the Bush Administration would scale 
back or eliminate the rules altogether,55 HHS Secretary Tommy Thompson 
 
 46. HIPAA, Pub. L. No. 104-191, § 264(c)(1) (1996). 
 47. See Amy Goldstein & Robert O’Harrow, Bush will Proceed on Patient Privacy; But 
Clinton-Era Rules Likely to be Modified, WASH. POST, Apr. 13, 2001, at A1.  This, however, is 
nothing new.  A 1998 Center for Public Integrity report found that “[t]ime and time again . . . 
Congress has put big-money corporate interests ahead of the basic privacy interests of the 
American people.”  THE CENTER FOR PUBLIC INTEGRITY, NOTHING SACRED: THE POLITICS OF 
PRIVACY (1998), available at http://publicintegrity.org/nothing_sacred.html (last visited Nov. 4, 
2001). 
 48. See Press Release, U.S. Department of Health and Human Services, Protecting the 
Privacy of Patients’ Health Information (May 9, 2001), available at http://aspe.hhs.gov/ 
admnsimp/final/pvcfact2.htm [hereinafter HHS Press Release]; Goldstein & O’Harrow, supra 
note 47. 
 49. HIPAA, Pub. L. No. 104-191, § 264(c)(1) (1996). 
 50. Standards for Privacy of Individually Identifiable Health Information, 64 Fed. Reg. 
59,918 (Nov. 13, 1999). 
 51. See HHS Press Release, supra note 48. 
 52. Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg. 
82,462 (Dec. 28, 2000). 
 53. See Robert Pear, Bush Accepts Rules to Protect Privacy of Medical Records, N.Y. 
TIMES, Apr. 13, 2001, at A1 [hereinafter Pear, Bush Accepts Rules]. 
 54. See Press Release, Secretary Thompson, supra note 2; HHS Press Release, supra note 
48. 
 55. See HEALTH PRIVACY PROJECT, COMMENTS ON THE FINAL FEDERAL STANDARDS FOR 
PRIVACY OF INDIVIDUALLY IDENTIFIABLE HEALTH INFORMATION 3 (2001), available at 
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announced on April 12, 2001, that the final rule as previously constructed 
would go forward, subject to interpretive guidelines developed by HHS.56  The 
first of these guidelines was released in July, 2001, with Secretary Thompson 
intending to write more.57  The rules take effect for most covered entities on 
April 12, 2003, and a year later for small health plans. 
Despite its convoluted development, the health data privacy rule provides a 
variety of privacy protections for health care consumers.58  The standard 
applies to covered entities, such as health care plans, health care 
clearinghouses and health providers, along with their business entities.59  HHS 
regulates individually-identifiable health information, meaning PHI, derived 
from electronic, written and oral communications.60  Uses and disclosures are 
subject to consent requirements, so as to prevent harmful sharing of PHI.  
These consent requirements are of two broad types: (1) informed consent 
provisions relating to the use of health data for transactions that are standard in 
the delivery and payment of health care services; and (2) authorization 
requirements for disclosures of PHI for non-health care purposes.61 
Trade-offs between public good and personal privacy are manifested in 
certain exceptions to the authorization requirements for outside disclosures.  In 
general, PHI may not be disclosed without specific, written authorization, 
except: (1) to law enforcement officials; (2) to judicial and administrative 
proceedings; (3) for commercial marketing purposes; (4) to parents of 
unemancipated minors; (5) to “significant others,” such as family members, 
 
http://www.healthprivacy.org/usr_doc/55009.pdf (last visited Jan. 7, 2001) [hereinafter HEALTH 
PRIVACY PROJECT, COMMENTS]; see also Goldstein & O’Harrow, supra note 47; Robert Pear, 
White House Plans to Revise New Medical Privacy Rules, N.Y. TIMES, Apr. 8, 2001, at 22. 
 56. Press Release, Secretary Thompson, supra note 2; see Goldstein & O’Harrow, supra 
note 47; Pear, Bush Accepts Rules, supra note 53. 
 57. Office for Civil Rights, Department of Heath and Human Services, Standards for Privacy 
of Individually Identifiable Health Information, available at 
http://aspe.hhs.gov/admnsimp/final/pvcguide1.htm (last modified July 6, 2001) [hereinafter 
Office for Civil Rights Standards].  See Ceci Connelly, Guidelines on Patient Privacy Rules 
Issued; Administration Postpones Action on Parents’ Access to Minors’ Health Records, WASH. 
POST, July 7, 2001, at A6; Robert Pear, Administration Clarifies New U.S. Rules Guarding 
Privacy of Patients, N. Y. TIMES, July 7, 2001, at A9. 
 58. To enforce these protections, the Secretary of HHS can investigate complaints and 
conduct compliance reviews.  See 45 C.F.R. §§ 160.306, 160.308 (2001).  Violations of the 
standard can lead to civil and criminal penalties up to $250,000 and ten years in prison.  See HHS 
Press Release, supra note 48.  There is no private right of action for individuals to redress 
violations. 
 59. See Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg. 
82,462, 82,475 (Dec. 28, 2000). 
 60. Unless the context otherwise requires, all further references to health information refer 
only to individually-identifiable data. 
 61. See Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg. 
at 82,509. 
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close friends, or designated persons, of an adult or emancipated minor, (6) to 
an authorized public health authority, and (7) for health research.62 
The rule also requires covered entities to develop privacy and security 
policies to protect stored health information.  Fair information practices set 
forth in the rule include a patient’s right to:  (1) receive notice of covered 
entities’ privacy practices and potential uses and disclosures of health 
information;63 (2) review one’s PHI;64 (3) request amendments to one’s PHI;65 
and (4) request confidential communications and an accounting of actual 
disclosures.66  The regulation generally does not preempt any state law that is 
more stringent than the health data privacy rule.67  Thus, states may impose 
stricter privacy provisions. 
As will be discussed below, the rule endeavors to set a national base-line 
of health information privacy protection.  Individual privacy, however, is 
sometimes under-protected or overprotected within that standard. 
A. The Scope of the Standard 
At least two questions arise in the development of a national health 
information privacy standard.  First, what information should be protected?  
Secondly, from whose actions should the information be protected?  In the 
health data privacy rule, these questions are partially answered by the limits of 
HHS’s authority under HIPAA.68 
1. Protected Health Information (PHI) 
The regulation explicitly covers health information69 that is individually-
identifiable.70  Individually-identifiable health information includes any data 
 
 62. See generally 45 C.F.R. § 164.512 (2001).  In the interest of space and concise 
discussion, this Article focuses on the most controversial and significant exemptions to the 
consent requirements.  However, the rule contains additional exemptions for treatment 
emergencies, communication difficulties between patient and provider, legal mandates for 
treatment, health oversight activities, decedents, serious threats to health or safety and military 
and veteran’s activities.  See id. §§ 164.506(a)(3)(i), 164.512. 
 63. See § 164.520(a). 
 64. § 164.524(a). 
 65. § 164.526(a). 
 66. § 164.528(a). 
 67. § 160.203(b). 
 68. For a discussion on the constitutional issues raised because of jurisdictional concerns 
related to HIPAA, see A. Craig Eddy, A Critical Analysis of Health and Human Services’ 
Proposed Health Privacy Regulations in Light of The Health Insurance Privacy and 
Accountability Act of 1996, 9 ANNALS HEALTH L. 1, 50-60 (2000). 
 69. “Health information” is comprehensively defined as data 
(1) . . . created or received by a health care provider, health plan, public health authority, 
employer, life insurer, school or university, or health care clearinghouse; and (2) 
[r]elate[d] to the past, present, or future physical or mental health or condition of an 
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that contains unique identifiable characteristics, including a name, social 
security or driver’s license number, fingerprint and genetic link.71  Where 
health data are truly non-identifiable, there are no individual privacy 
implications relating to its access, use or disclosure.  Thus, such data require 
no privacy protection.  Excluding non-identifiable health data (for example, 
aggregate statistical data, non-linked data or other data stripped of all 
individual identifiers) provides an incentive for data holders to use or de-
identify health information to diminish the risk of harmful disclosures and uses 
of personal data.72  Under the standard, HHS permits covered entities to assign 
codes73 to allow for later re-identification but requires steps be taken to prevent 
harmful identifications.74 
HHS defines PHI to include all forms of information, including electronic, 
oral and paper communications.75  It is impractical to separate protections for 
 
individual; the provision of health care to an individual; or the past, present, or future 
payment for the provision of health care to an individual. 
§ 160.103. 
 70. § 164.514 (discussing procedures for de-identification of health information).  HHS 
defines individually-identifiable health information as health information which “identifies an 
individual or with respect to which there is a reasonable basis to believe the information can be 
used to identify the individual.”  § 164.501.  The regulatory definition limits the term to only a 
subset of health information, specifically that created or received by health care providers, health 
plans, employers or health care clearinghouses.  See id. 
 71. The health data privacy rule outlines two means for determining if health information is 
not individually-identifiable (“de-identified”) and thus no longer regulated by the rule.  First, an 
expert utilizing accepted analytic techniques can conclude that “the risk is very small that the 
information could be used, alone or in combination with other reasonably available information” 
to identify the subject of the information.  § 164.514(b)(1).  A second permitted means of de-
identification is that the covered entity can remove a comprehensive set of identifiers of the 
individual and of relatives, employers and household members of the individual.  These 
identifiers include names, geographic subdivisions smaller than a state, dates more specific than 
years, contact information such as telephone and fax numbers and email addresses, identification 
numbers such as social security numbers, account and medical record numbers, license place 
numbers and full face photographic images.  § 164.514(b)(2)(i). 
 72. See HEALTH PRIVACY PROJECT, BEST PRINCIPLES FOR HEALTH PRIVACY 15-16 (1999), 
available at http://www.healthprivacy.org/usr_doc/33807.pdf (last visited Nov. 4, 2001) 
[hereinafter HEALTH PRIVACY PROJECT, BEST PRINCIPLES]; HEALTH PRIVACY PROJECT, 
COMMENTS, supra note 55, at 18. 
 73. Information can be “ostensibly anonymous,” yet linkable to an individual because of 
codes frequently utilized by health care organizations, researchers and the government.  Concern 
is raised about deliberate or accidental disclosures of coded information, not literally protected by 
law, where the code is broken or inadequate.  Gostin, Health Information Privacy, supra note 4, 
at 520. 
 74. The code must not be derived from or related to information about the individual or able 
to be translated so that the individual can be identified.  See § 164.514(c)(1).  The covered entity 
must also not disclose or use the code for other purposes than record identification and cannot 
disclose the mechanism for re-identification.  See § 164.514(c)(2). 
 75. § 164.501 (defining “protected health information”). 
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paper-based records from electronic or oral-based data.  HHS’s attempt to 
cover all types of health data, however, is controversial.  Congress may not 
have granted clear authority to HHS to regulate non-electronic communication 
in HIPAA.76  Although HHS maintains it has “ample legal authority” to 
regulate non-electronic communications,77 the regulation is structured so that 
non-electronic communications are severable by court action from electronic 
communications.78  Alternatively, by protecting all health information, the 
efficacy of the regulation would be enhanced.  Otherwise, a significant amount 
of non-electronic health communications would remain unregulated by federal 
law.  There would be complications in enforcing a national standard applicable 
to only some types of health data, depending on how they were communicated 
or stored.79 
2. Covered entities. 
HHS regulates the actions of “covered entities” that it has authority to 
reach under HIPAA.  These “covered entities” include health plans, health care 
 
 76. Section 264 of HIPAA, which contains the Congressional mandate to HHS to develop 
the privacy standard, evolved because of the administrative simplification goals of the statute 
related to electronic information exchange.  See Standards for Privacy of Individually Identifiable 
Health Information, 65 Fed. Reg. 82,462, 82,469 (Dec. 28, 2000); see also Eddy, supra note 68, 
at 18.  Some commentators have suggested that because section 264 was developed to counteract 
negative effects of the administrative simplification provisions, HHS could only regulate privacy 
concerns for the narrow set of electronic transactions covered in those provisions.  See Eddy, 
supra note 68, at 19-20.  However, section 264 of HIPAA describes the scope of HHS authority 
in terms of regulation of individual rights over “individually identifiable health information,” not 
electronic transactions or administrative simplification.  Health Insurance Portability and 
Accountability Act of 1996, Pub. L. No. 104-191, 110 Stat. 1936, 2033 (1996).  The statute states 
that if Congress does not meet its deadline, HHS must “at least” develop regulations that address: 
“(1) [t]he rights that an individual who is a subject of individually identifiable health information 
should have[;] (2) [t]he procedures that should be established for the exercise of such rights[; and] 
(3) [t]he uses and disclosures of such information that should be authorized or required.”  Id.  
This subsection provides the requirements for HHS’s recommendation to Congress when 
Congress is considering legislation before its self-imposed deadline has passed.  Based on a 
cross-reference to 264(b), 264(c) applies these requirements to the regulations that are mandated 
if Congress does not meet its deadline.  See id.  The use of “at least” and the lack of a reference to 
the administrative simplification sections or electronic transactions in these detailed requirements 
suggests that Congress did not intend to limit HHS to protecting privacy in electronic transactions 
only.  See HEALTH PRIVACY PROJECT, COMMENTS, supra note 55, at 5.  Nevertheless, ambiguity 
remains about HHS’s scope of authority. 
 77. Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg. at 
82,496. 
 78. See id.  In a successful court challenge to the broad coverage, then the judge could order 
that the phrase “regarding non-electronic information” be struck from the regulation while the 
standard would remain intact for electronic communications. 
 79. See HEALTH PRIVACY PROJECT, COMMENTS, supra note 55, at 6-7. 
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clearinghouses and health care providers.80  Health plans, which provide or pay 
for the cost of medical care, are covered whether they are private entities (such 
as a health insurer or managed care organization) or government organizations 
(such as Medicaid, Medicare or the Veterans Administration).81  Health care 
providers (meaning physicians, hospitals or clinics) are covered if they 
“[transmit] any health information in electronic form in connection with a 
transaction covered by [the regulation].”82  Such electronic exchanges can 
include billing and fund transfers in addition to health information 
communications. 
The rule also covers business associates of the covered entities.  Business 
associates are lawyers, accountants, billing companies and other contractors 
whose positions involve the use or disclosure of individually-identifiable 
health information.83  Although HHS lacks the authority to directly regulate 
business associates, it requires covered entities to obtain “satisfactory 
assurance[s] that [their] business associates will appropriately safeguard the 
information.”84  Should a covered entity know of a violation and do nothing to 
address it, the covered entity may be considered to have violated HIPAA’s 
privacy standards.85  While covered entities have protested that this is unfair, 
this technique was maintained by HHS in the final rule as a way to regulate the 
downstream users and processors of PHI.86 
Though the regulations are facially comprehensive in their coverage, not 
all persons or entities who regularly use, disclose or store identifiable health 
data are covered.  For example, the rule does not cover groups such as life 
insurance companies or worker’s compensation insurance companies and 
programs, even though these entities regularly use personal medical 
information.87  Additional protections governing all identifiable health data, 
 
 80. § 160.102(a). 
 81. § 160.103 (defining “health plan”).  Employers utilizing employer-sponsored health 
plans, governed by ERISA, are not considered covered entities when administering the plan (as 
“plan sponsors”).  Id. (listing exclusions to the definition of “health plan”).  However, the 
standard outlines numerous requirements for employer-sponsored health plans, as covered 
entities, to disclose PHI to plan sponsors/employers, including an agreement that the sponsor will 
not use or disclose the information for employment decisions.  § 164.504(f)(1)-(2) (2001). 
 82. § 160.102(a)(3). 
 83. See § 160.103. 
 84. § 164.502(e)(1)(i). 
 85. See § 164.502(e)(1)(iii). 
 86. See Lawrence O. Gostin, National Health Information Privacy: Regulations Under the 
Health Insurance Portability and Accountability Act, 285 JAMA 3015, 3016 (2001) [hereinafter 
Gostin, Regulations under HIPAA]. 
 87. See generally James G. Hodge, Jr., The Intersection of Federal Health Information 
Privacy and State Administrative Law: The Protection of Individual Health Data and Worker’s 
Compensation, 51 ADMIN. L. REV. 117 (1999). 
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regardless of the holder or manner of communication, are needed to complete a 
national standard of health information privacy. 
B. Consenting to Uses and Disclosures of Protected Health Information 
Regulating the use and disclosure of PHI is essential in assuring patients’ 
privacy because of the potential risk of harm from unlimited sharing of 
personal medical data.  Requiring informed consent for uses and disclosures 
allows individuals some degree of control over their individually-identifiable 
health information.  HHS augments consent protections by imposing a 
minimum disclosure standard that limits the amount of information that can be 
shared.  The standard requires that when using, disclosing or requesting PHI, 
the covered entity must make reasonable efforts to limit the disclosure to the 
minimum amount of information necessary to accomplish an otherwise lawful 
purpose.88  Collectively, these measures can enhance patient autonomy and 
promote trust in the health care system.89  The minimum disclosure standard 
helps patients maintain their privacy in transactions, such as reimbursement, 
where only specific health information is required and additional disclosures 
could lead to harm to patients.90  Informed consent mechanisms are featured in 
the health data privacy rule with mixed success.  Written authorization 
requiring disclosures of health data for non-health care purposes is effective in 
protecting individual privacy.  However, written consent requiring disclosures 
for treatment, payment and health care operations fails to protect individuals 
and burdens covered entities. 
1. Written Consent for Disclosure and Use for Health Care Purposes 
The consent rule requires covered health care providers to obtain written 
consent from individuals before using or disclosing information for treatment, 
payment or health care operations.  Such consent must (1) be in plain 
language,91 (2) inform the individual that PHI may be used and disclosed to 
 
 88. § 164.502(b)(1). 
 89. See Gostin, Health Information Privacy, supra note 4, at 522.  For further discussion, see 
HEALTH PRIVACY PROJECT, COMMENTS, supra note 55, at 22-33 (arguing that personally 
identifiable health information should not be disclosed without authorization except in limited 
circumstances). 
 90. HHS’s recent guidance has clarified a significant concern of health care providers over 
the permitted uses during treatment when consulting with other physicians or medical staff.  The 
standard as written specifies that the minimum disclosure requirement applies for use of PHI 
during treatment by health care providers, but not disclosures.  This has caused confusion about 
how health care providers can utilize vital health information in the course of treatment as they 
work with other medical professionals.  In the July, 2001 guidance, HHS explained that the 
exemption for disclosures during treatment allows health care providers to share information with 
other providers.  See Office for Civil Rights Standards, supra note 57. 
 91. § 164.506(c). 
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carry out those activities,92 (3) indicate that the individual can revoke the 
consent in writing93 and (4) state that the individual may request that the 
covered entity restrict how PHI is used or disclosed for health care purposes, 
though the covered entity is not required to agree.94  Certain exceptions for 
specific disclosures are discussed below. 
The written consent requirement for use and disclosure of PHI in health 
care activities is largely inadequate.95  Consent under these circumstances is 
neither informed nor consensual.  A patient may sign a consent form on his 
first visit to a physician that applies to all future disclosures and uses.  In such 
cases, the individual will not be aware of the substance of the data protected 
because he will typically not know what information is contained in his current 
records, or what may be contained in his future medical records.96  At the time 
of consent, he will also not be aware of the specific uses or disclosures because 
the consent form need only state “treatment, payment, or health care 
operations.”97  For these reasons, his execution of a written authorization prior 
to treatment is uninformed.  Such authorization also lacks effective consent 
where the rule allows providers to condition enrollment in a plan or medical 
treatment on whether the individual signs the consent.98  As a result, the patient 
can be forced to consent if he wants to obtain treatment or health insurance.99 
The written consent requirement also creates significant burdens for the 
health care industry.  While many health providers already maintain individual 
informed consent as part of most health care transactions, all covered entities 
will have to develop mechanisms to obtain, access and store consent forms 
from every individual.  Health care providers have the additional concern of 
having to delay treatment because consent forms are lost or unsigned.100 
 
 92. § 164.506(c)(1)-(2).  The consent may not be combined in a single document with the 
notice.  § 164.506(b)(3). 
 93. § 164.506(c)(5). 
 94. § 164.506(c)(4).  If the covered entity does agree, the agreement is binding.  See § 
164.522(a) (restating the standard for an individual’s right to request restrictions of uses and 
disclosures and documenting the requirements for termination of the restrictions). 
 95. Note that the consent requirement was not in the proposed rule. 
 96. See Gostin, Regulations under HIPAA, supra note 86, at 3017. 
 97. § 164.506(c)(1). 
 98. § 164.506(b)(1)-(2). 
 99. See HEALTH PRIVACY PROJECT, COMMENTS, supra note 55, at 22. 
 100. See id.  A further burden is placed on the practices of pharmacists.  As the regulation is 
currently written, pharmacists cannot use PHI to fill a prescription that was telephoned by the 
individual’s doctor if the patient is a new patient to the pharmacy and has not given written 
consent to the pharmacy.  HHS has indicated in the guidance issued in July, 2001 that this is an 
undesirable outcome and it plans to issue a proposed rule to rectify this concern.  Office for Civil 
Rights Standards, supra note 57.  Without such a change, a sizable delay and burden on 
pharmacies and patients could occur.  Patients would have to visit the pharmacy to sign the 
consent form, wait for the prescription to be filled and then return to pick up their prescriptions at 
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2. Authorization for Disclosure and Use Not Related to Health Care 
A different consent model for disclosures and uses of PHI unrelated to 
health care is employed in the rule.  Such disclosures of PHI may be made for 
employment decisions or the evaluation of credit status.  Prior to using or 
disclosing PHI for non-health care purposes, covered entities must obtain an 
authorization from the individual.  The authorization, unlike the written 
consent required for health care purposes, contains specific information to help 
individuals decide whether to permit disclosure or use.  Such authorizations 
must (1) identify the information to be used or disclosed in a “specific and 
meaningful fashion;”101 (2) provide the names of the persons or organizations 
who will make and receive the use or disclosures;102 (3) explain the purpose for 
each request;103 (4) notify the individual of his right to refuse to sign the 
authorization without negative consequences to treatment or health plan 
eligibility (except under specific circumstances);104 (5) be written in plain 
language105 and feature an expiration date;106 and (6) explain that the 
individual has a right to revoke the authorization107 at any time in writing 
except regarding actions taken by the covered entity in reliance of the 
authorization.108  This authorization process better protects patients’ privacy 
than the written consent requirement because covered entities generally may 
not condition treatment or insurance enrollment on a patient’s signature of the 
authorization.109 
 
the pharmacies, while the pharmacies would have to devise a method to store and process the 
consents.  See Gostin, Regulations under HIPAA, supra note 86, at 3017. 
 101. § 164.508(c)(1)(i). 
 102. § 164.508(c)(1)(ii)-(iii). 
 103. § 164.508(d)(1)(ii). 
 104. § 164.508(e)(1). 
 105. § 164.508(c)(2). 
 106. § 164.508(c)(1)(iv). 
 107. § 164.508(c)(1)(v)-(vi). 
 108. § 164.508(b)(5)(i). 
 109. § 164.508(b)(4).  There are some limited exceptions.  One is that health care providers 
may condition provision of research-related treatment on authorization.  §164.508(b)(4)(i).  
Another is that if the covered entity is gathering individually-identifiable health information 
solely for the purposes of disclosing it to a third party, such as an employer, the covered entity 
may condition this care on the authorization to disclose it to the third party.  § 164.508(b)(4)(iv).  
Further protection is offered regarding psychotherapy notes.  Authorization is always required for 
use and disclosure of psychotherapy notes except in specified health care operations.  
§ 164.508(a)(2). 
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3. Making Exceptions: Balancing Communal Goods and Personal 
Privacy 
The privacy rule makes several exceptions to the informed consent and 
authorization provisions related to the use of disclosure of PHI.  These 
exceptions include: 
a. Law Enforcement 
A covered entity may disclose PHI to a law enforcement official without 
informed consent pursuant to a court order, subpoena or administrative request, 
including a civil investigative demand or an administrative subpoena.110  
Judges are given no criteria from which to make their determination as they 
balance individual privacy and law enforcement.  In addition, a covered entity 
may disclose limited information111 without prior judicial approval where: (i) 
the information relates to a crime victim who is incapacitated and disclosure is 
necessary and in the best interests of the individual;112 (ii) PHI is evidence of 
“criminal conduct that occurred on the premises of the covered entity;”113 and 
(iii) in the course of an emergency, disclosure is necessary to alert law 
enforcement to the location, commission and nature of the crime, victims or 
perpetrators.114 
b. Judicial and Administrative Proceedings 
PHI may be disclosed in any judicial or administrative proceeding without 
the person’s permission in response to an order of the court overseeing the 
proceeding.115  As in the law enforcement context, judges are given no criteria 
in the rule to exercise their discretion.  Covered entities may also disclose 
health information in response to a subpoena or discovery request if the 
 
 110. See § 164.512(f)(1).  When an administrative request is utilized, the rule lays out certain 
requirements: (1) the information sought must be “relevant and material to a legitimate law 
enforcement inquiry;” (2) the request must be “specific and limited in scope to the extent 
reasonably practicable;” and (3) de-identified information must not be able to be reasonably used.  
§ 164.512(f)(1)(C). 
 111. § 164.512(f)(2)(i).  The permitted information is name, address, date and place of birth, 
social security number, blood type, type of injury, date and time of treatment and a description of 
distinguishing characteristics.  Id. 
 112. § 164.512(f)(3).  The specific criteria are: (1) the law enforcement official represents that 
the information is needed to determine whether a crime occurred by an individual other than the 
victim and that the information will not be used against the victim; (2) the law enforcement 
official represents that immediate law enforcement activities would be jeopardized by waiting for 
consent; and (3) the covered entity determines that the disclosure is in the best interest of the 
individual.  § 164.512(f)(3)(iii).  If the patient is competent and no emergency exists, the patient 
must agree under the exception for the disclosure to occur.  § 164.512(f)(3)(i). 
 113. § 164.512(f)(5). 
 114. § 164.512(f)(6). 
 115. § 164.512(e). 
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requester (i) reasonably attempts to inform the patient of the disclosure;116 or 
(ii) reasonably attempts to obtain a protective order to prohibit the recipients 
from using or disclosing the information for purposes other than the 
litigation.117  Instead of placing the burden on litigants seeking the information, 
the rule requires that patients make objections to the court.  
c. Minors 
Disclosures to parents of unemancipated minors are exempted from 
consent requirements in multiple cases.  If state law forbids or requires that 
parents be informed about their children’s health conditions, the rule allows 
state law to stand.118  While many states permit competent minors to receive 
medical treatment for potentially stigmatizing conditions without parental 
consent,119 states could pass laws requiring parents to be informed about their 
child’s condition and treatment.  Where no state law exists, the rule allows 
parents to serve as personal representatives,120 who generally can act on behalf 
of the individual121 child under some restrictions.122  The Bush Administration 
has suggested that it may modify the rule to increase parental access.123 
 
 116. § 164.512(e)(1)(ii)(A).  The covered entity must obtain satisfactory assurances that the 
party requesting information has made a good faith attempt to provide written notice to the 
individual and that the notice included sufficient information about the litigation to permit the 
individual to raise an objection in the proceedings.  § 164.512(e)(1)(iii)(A) & (B).  The covered 
entity must also be given assurances that the time for the individual to raise objections to the 
court has elapsed and that any objections given were resolved in the favor of the requester.  
§ 164.512(e)(1)(iii)(C). 
 117. § 164.512(e)(1)(ii)(B).  The party requesting information must give the covered entity 
satisfactory assurances that the parties have agreed to a qualified protective order or that the 
requester has asked for a qualified protected order.  § 164.512(e)(1)(iv).  The standard defines 
qualified protective order as one that prohibits the parties from using or disclosing PHI for any 
purpose other than litigation or proceeding for which the information was requested and requires 
the PHI’s return to the covered entity or destruction at the end of the proceeding.  
§ 164.512(e)(1)(v). 
 118. See § 160.202 (defining “more stringent”). 
 119. See Gostin, Regulations under HIPAA, supra note 86, at 3017. 
 120. See § 164.502(g)(1). 
 121. § 164.502(g)(2). 
 122. § 164.502(g)(3).  If the minor consents to the health care service, the parent agrees to 
confidentiality between provider and the minor, or if the minor consents and does not wish the 
parent to be the personal representative, then the parent is not considered a personal 
representative. Id. 
 123. See Press Release, Secretary Thompson, supra note 2 (“we will make it clear through 
guidelines or recommended modifications that . . . parents will have access to information about 
the health and well-being of their children, including information about mental health, substance 
abuse or abortion”).  Id.  The July, 2001 guidance indicated the Secretary is still considering such 
action.  See Office for Civil Rights Standards, supra note 57 (referring to statements in the section 
on “Parents and Minors”). 
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d. “Significant Others” of Adults and Emancipated Minors 
Disclosures to “significant others” (meaning family, friends, caretakers or 
health care surrogates) of adults and emancipated minors are narrowly 
exempted.  Covered entities may disclose limited health information to 
“significant others” without consent if the patient is informed in advance and 
has the opportunity to agree.124  The disclosed PHI must be (i) directly relevant 
to the person’s involvement with the patient’s care or payment for care;125 or 
(ii) used to notify that person of the patient’s location, general health condition, 
or death.126  In cases of incapacitation or emergency, disclosures to “significant 
others” may be made in the patient’s best interest when directly relevant to the 
entity’s involvement with the individual’s care.127 
e. Public Health 
The health data privacy rule broadly exempts128 disclosures of PHI for 
routine public health activities.129  This includes disclosures: (i) where federal 
or state law authorizes public health authorities130 to collect PHI to prevent or 
control disease, injury or disability, or report child abuse or neglect; (ii) to 
notify persons who may be at risk for or exposed to a communicable disease 
(for instance, partner notification provisions);131 (iii) concerning adverse 
events, tracks and recalls of products, and post marketing surveillance by 
persons subject to the jurisdiction of the Food and Drug Administration.132  
State reporting or other public health laws that offer more stringent privacy 
protections are not preempted by the rule.133 
f. Health Research 
Most federally-funded human subject research is currently governed by a 
federal regulation known as the Common Rule,134 which does not contain 
 
 124. See 45 C.F.R. § 164.510(b)(1) & (2) (2001).  Disclosure is also permitted if the covered 
entity can reasonably infer from the circumstances that the patient does not object to disclosure. 
See § 164.510(b)(2)(iii). 
 125. § 164.510(b)(1)(i). 
 126. § 164.510(b)(1)(ii). 
 127. § 164.510(b)(3).  The rule allows relatives and close personal friends to perform 
common care-taking duties such as picking up prescriptions, medical supplies, et cetera.  Id. 
 128. § 164.514(b)(2) (clarifying that all of the exceptions apply to uses of PHI, as well as 
disclosures in the public health exemptions section). 
 129. See Gostin, Regulations under HIPAA, supra note 86, at 3019. 
 130. Public health authority is expansively defined as a federal, tribal, state or local agency or 
authority, or a person or entity with a grant of authority from or contract with the agency that is 
responsible for public health matters as part of its official mandate.  45 C.F.R. § 164.501. 
 131. § 164.512(b)(1)(i)(ii), (iv). 
 132. § 164.512(b)(1)(iii), (v). 
 133. § 160.203(b). 
 134. Protection of Human Subjects, 56 Fed. Reg. 28003 (1991) (codified at 45 C.F.R. pt. 46). 
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detailed privacy standards.  Rather, this rule conditions institutional review 
board (IRB) approval of research on whether “there are adequate provisions to 
protect the privacy of subjects . . . .”135  Though the Common Rule is a helpful 
guide for protecting the privacy and other ethical interests of human research 
subjects, it does not apply to privately-funded research.  The health data 
privacy rule closes this gap between the federal and private sectors by 
providing more detailed requirements than the Common Rule.  A covered 
entity may only use or disclose PHI for research without the person’s 
permission if it obtains a waiver from an IRB or privacy board136 that finds: (i) 
the use or disclosure involves no more than minimal risk; (ii) the waiver will 
not adversely affect the privacy rights and welfare of the individuals; (iii) the 
research could not practicably be conducted without the waiver; (iv) the 
research could not be conducted without the protected health information; (v) 
the privacy risks are reasonable in relation to the anticipated benefits, if any, to 
individuals and the importance of the research; (vi) a plan exists to protect the 
identifiable information from improper use and disclosure; (vii) a plan to 
destroy the identifiers exists unless there is a health or research justification for 
retaining them; and (viii) there are written assurances that the data will not be 
reused or disclosed to others, except for research that would also qualify for a 
waiver.137  Researchers must also show that PHI is necessary for the research, 
will not be disclosed to outsiders and is sought solely to prepare for the 
research.138  While certain critics are concerned about the burdens imposed by 
the new requirements,139 the standard fairly ensures that there are valid 
justifications for utilizing PHI for research without consent. 
g. Commercial Marketing 
In contrast to some of the other exceptions, which offer either greater or 
similar protections than the law currently provides, the exception for 
 
 135. Protection of Human Subjects, 45 C.F.R. § 46.111(a)(7).  In the Common Rule, if 
consent is required, the researcher must provide the subject with “[a] statement describing the 
extent, if any, to which confidentiality of records identifying the subject will be maintained . . . .”  
45 C.F.R. §  46.116(a)(5).  The Common Rule also applies to research conducted in anticipation 
of Food and Drug Administration approval. 
 136. § 164.512(i)(1)(i).  The privacy board must have members with varying backgrounds, 
appropriate professional competency and no conflict of interest.  § 164.512(i)(1)(i)(B).  At least 
one member must be unaffiliated with the covered entity and research entity.  § 
164.512(i)(1)(i)(B)(2).  This includes relatives of individuals affiliated with the organizations.  Id. 
A majority of the privacy board must be present when considering a waiver, including the 
unaffiliated member.  § 164.512(i)(2)(iv)(B). 
 137. § 164.512(i)(2)(ii). 
 138. § 164.512(i)(1)(ii).  See Mark Barnes & Sara Krauss, The Effect of HIPAA on Human 
Subject Research, 10 HEALTH L. REP. 1026, 1030-31 (2001). 
 139. See, e.g., Barnes & Krauss, supra note 138, at 1031 (arguing that IRB’s are ill-prepared 
to make the assessments now required of them by the health data privacy rule). 
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commercial marketing provides for less privacy protection by condoning the 
use or disclosure of PHI for commercial marketing without consent.140  PHI 
may be used or disclosed without consent for marketing communications to the 
individual that occur in face-to-face encounters (whether health-related or not), 
concern products or services of nominal value, or concern health-related 
products and services of the covered entity or a third party.141  A covered entity 
may target persons based on their health status if the product or service may be 
beneficial to them.142  Thus, under this exception, a non-physician salesperson 
can approach individuals with potentially stigmatizing conditions (such as 
HIV, pregnancy or mental illness) at their residences and inform them that he 
learned of their illness without their consent and would like to sell or offer 
information about a product. 
4. Principles to Guide Disclosure Exceptions 
Many of these exceptions sacrifice individual autonomy regarding personal 
privacy interests for the sake of communal goods and commercial interests.  In 
certain contexts, such trade-offs may be appropriate, especially when HHS’s 
broader goal of enhancing the health of the population is achieved.  Yet, as 
with many existing health information privacy laws, some disclosure 
exceptions to an informed consent requirement lack credibility and may be 
ethically unsound.  Exceptions in a health information privacy statute must be 
ethically justified to enhance individual trust in the health care system and 
improve health outcomes, consistent with the following principles: 
a. Further Health Care Purposes 
While most exchanges of health data in the electronic health information 
infrastructure should be made only after an individual’s consent, some 
disclosures may be justifiable without informed consent when made for health-
related purposes.  Disallowing such disclosures could negate advancements in 
individual or populational health outcomes by denying access to health data to 
persons with a legitimate need to know.  Public health and research activities 
clearly advance this aim, as do limited disclosures to “significant others” in the 
case of medical emergencies or basic care-taking activities (such as picking up 
prescriptions or X-rays).  In contrast, exemptions for law enforcement, judicial 
and administrative proceedings and commercial marketing do not serve to 
improve individual and public health outcomes. 
 
 140. Robert Gellman, Analysis of the Marketing Provisions of the HIPAA Privacy Rules, 
available at http://www.hipaadvisory.com/action/privacy/marketing.htm (last modified Jan. 
2001). 
 141. § 164.514(e)(2). 
 142. § 164.514(e)(3)(ii)(A). 
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b. Operate in the Individual’s Best Interest 
Ethical principles support non-consensual disclosures made to directly 
benefit the subject of PHI through the delivery of clinical care or the provision 
of other health services (such as the disclosure exception for “significant 
others” of adults or emancipated minors whose best interests are explicitly 
considered by the covered entity in case of emergency or the patient’s 
incapacity).  Of less benefit is the ability of parents to obtain PHI of minors 
regarding treatment for potentially stigmatizing conditions such as pregnancy 
or sexually-transmitted diseases where state laws permit such disclosures.  
Minors fearing punishment may avoid treatment to the detriment of their 
individual well-being.  Avoiding treatment might also result from exceptions 
for law enforcement and judicial and administrative proceedings, where PHI 
can ultimately be used to punish individuals (such as for criminal actions) or 
reduce judicial remedies (for example, in workers’ compensation cases to show 
a pre-disposition to a relevant injury).143 
c. Promote Communal Health While Minimally Threatening Individual 
Privacy 
Where the benefits of public health and research relate to society, as well 
as individuals, non-consensual disclosures of PHI for such communal, health-
related goods (such as public health and health research) are justified.  Public 
health practice has traditionally relied on these disclosures as authorized 
through federal, state and local laws.  Human research (in some cases) may 
necessitate the need to use PHI without informed consent.  Though the 
autonomous interests of the individual are infringed through these disclosures, 
the utilitarian premise that individuals should contribute to these greater goods 
in society sustains these types of disclosures. 
d. Disregard Commercial Interests of Health Care Industry 
Like public health authorities and researchers, private industry (health 
insurers, pharmaceutical companies and medical products providers, for 
instance) may claim a need for PHI to provide products, services or knowledge 
that improve individual and communal health.  In some cases, these claims are 
legitimate.  However, where access to PHI is undergirded by profit-oriented 
goals of recipients in the private sector (as contrasted with the community-
oriented goals of government or academic researchers), the claim for non-
consensual access to PHI is unjustified.  People may choose to participate in 
private sector research or marketing campaigns, but should not have to.  The 
commercial marketing exception unacceptably permits broad disclosures based 
on a pure profit motive before individuals have a chance to object. 
 
 143. See Hodge, supra note 87, at 120. 
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C. Privacy and Security Policies for Covered Entities 
In addition to an individual’s right to control uses and disclosures, the 
development of privacy and security policies for covered entities is important 
to prevent privacy breaches and maintain consumers’ trust in the health care 
system.  Without such policies, accidental disclosures from sloppy record 
keeping and purposeful disclosures by and to unscrupulous parties may 
proliferate.144  Addressing these concerns, the health data privacy rule 
mandates that covered entities develop privacy and security policies while 
maintaining the flexibility necessary for the large variety of participants 
covered by the rule.145  Covered entities must implement policies that 
reasonably protect from any “intentional or unintentional use or disclosure in 
violation of the standards, implementation specifications or other 
requirements.”146  Covered entities must not only guard against a deliberate 
attempt to use protected information, but also must endeavor to prevent 
accidental uses and disclosures.  Procedures must be developed to allow for 
complaints about the policies or the covered entities’ compliance with the 
policies.147  Staff members who violate privacy policies may be sanctioned.148 
A covered entity may not require an individual to waive these rights in 
order to receive care, enroll in a health plan or obtain benefits.149  However, 
covered entities are not mandated to create a formal appeals process or a form 
of “due process.”150  When violations occur, the covered entity must mitigate 
“to the extent practicable” any harmful effect known to result from the 
infraction.151 
 
 144. For more on the impact on personal privacy from security policies, see HEALTH 
PRIVACY PROJECT, BEST PRINCIPLES, supra note 72, at 20-22. 
 145. Specific concerns calling for flexibility include that the nature of the health information 
held by covered entities may differ, smaller organizations may be burdened greatly by 
requirements more appropriate for larger firms and the swift changes in technology may require a 
fast process to update the privacy and security policies.  See Gostin, Health Information Privacy, 
supra note 4, at 526. 
 146. 45 C.F.R. § 164.530(c)(2) (2001).  Group health plans that provide benefits only through 
a health maintenance organization (HMO) or an issuer and that do not create, receive or maintain 
PHI are not subject to any of the requirements under this section except documentation of their 
plan materials.  § 164.530(k).  The issuers and HMOs must still follow all of the elements of the 
privacy and security policy mandates.  See Standards for Privacy of Individually Identifiable 
Health Information, 65 Fed. Reg. 82,563-64 (Dec. 28, 2000). 
 147. § 164.530(d).  Covered entities are also forbidden from taking any “intimidating or 
retaliatory acts” against an individual involved in the privacy policy process, including those 
filing a complaint.  § 164.530(g). 
 148. § 164.530(e)(1). 
 149. § 164.530(h). 
 150. Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg. 
82,562 (Dec. 28, 2000). 
 151. § 164.530(f).  Balancing the protections for individuals requires flexibility for 
businesses.  Every covered entity is not compelled to develop the same privacy and security 
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D. Fair Information Practices 
Persons and entities maintaining PHI must adhere to a range of fair 
information practices that allow individuals to make informed choices about 
the delivery and financing of their health care.  The health data privacy rule 
proscribes several fair information practices for health consumers. 
1. Notice 
Health care consumers have the right to adequate notice of the uses and 
disclosures of PHI that may be made by the covered entity.152  Individuals are 
also entitled to know their rights and the covered entity’s legal duties regarding 
the new privacy and security policies and fair information practices 
requirements.153  The notice must be in plain language to prevent covered 
entities from employing legal language that may confuse individuals.154  The 
type of notice required is determined by the nature of the covered entity.155  
Several consumer safeguards apply to covered entities that pursue electronic 
notice.156 
 
policies.  Instead, the policies must be “reasonably designed, taking into account the size of and 
the type of activities that relate to PHI undertaken by the covered entity.”  § 164.530(i)(1).  This 
generalized description of the requirement allows small businesses to develop plans that reflect 
the nature and size of their enterprise without burdening them more than necessary.  Small 
businesses might still find some of the requirements overly burdensome.  For example, a sole 
practitioner largely relying on paper medical records might be challenged by the need to prevent 
accidental disclosure from a misplaced record.  As the health data privacy rule mandates that 
covered entities’ privacy policies “promptly” comply with changes in law, further difficulties can 
arise to small businesses with limited resources to monitor legal developments and implement 
swift changes.  § 164.530(i)(3).  See also Gostin, Regulations under HIPAA, supra note 86, at 
3018. 
 152. § 164.520(a)(1).  For more on the necessity of providing such notice, see Gostin, Health 
Information Privacy, supra note 4, at 522-24; HEALTH PRIVACY PROJECT, BEST PRINCIPLES, 
supra note 72, at 19-20. 
 153. § 164.520(a)(1).  The notice must include information about how individuals may 
complain about potential misuses or violations to the covered entity and the Secretary of HHS or 
contact the covered entity with questions.  § 164.520(b)(1)(vi). 
 154. § 164.520(b)(1). 
 155. § 162.520(c)(1), (2).  Health plans must provide notice to covered individuals by the 
compliance date of the regulation.  New enrollees must get the notice at the time of enrollment.  
At least once every three years, the health plan must notify enrollees in the plan that the notice is 
available and the methods by which they can obtain it.  § 164.520(c)(1).  In contrast, health care 
providers have to provide the notice upon the first service delivery after the compliance date.  § 
164.520(c)(2). 
 156. An individual must agree to obtain the notice via e-mail.  A paper copy must be provided 
if the covered entity knows that the e-mail transmission failed.  § 164.520(c)(3)(ii).  Health care 
providers must give electronic notice automatically and simultaneously when their first service 
delivery is electronic.  § 164.520(c)(3)(iii).  If a covered entity maintains a web site that offers 
information about its benefits and services, it must also prominently post its notice on the web 
site as well as make it available electronically.  § 164.520(c)(3)(i). 
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2. Access to Protected Health Information 
The new regulation offers individuals a broad opportunity to access their 
PHI.157  Access rights include an on-site inspection of the records and the 
provision of copies.158  Covered entities must act within thirty days upon the 
request.159  If the individual agrees in advance, the covered entity may provide 
a summary of the PHI instead of the actual documents.160  The standard does 
permit narrow reasons that cannot be reviewed for denial regarding requests 
for psychotherapy notes; information likely to be used in a civil, criminal or 
administrative proceeding; and requests by inmates to their correctional facility 
or health care provider that might threaten the health or safety of the individual 
or others.161  Also, in limited circumstances,162 a covered entity may deny 
access as long as the individual may request a review of the grounds for 
denial.163  If the covered entity decides to deny access to the individual of any 
part of the PHI, the rule ensures a fair and informed process.164 
 
 157. § 164.524 (2001).  The covered entity may require the request be in writing.  § 
164.524(b)(1).  For more on the significance of the individual’s ability to access their personal 
medical data, see Gostin, Health Information Privacy, supra note 4, at 524; HEALTH PRIVACY 
PROJECT, BEST PRINCIPLES, supra note 72, at 18-19. 
 158. § 164.524(c)(1). 
 159. Id. § 164.524(b)(2)(i).  Sixty days is allowed if the information is held off-site.  § 
164.524(b)(2)(ii).  Delay is also allowed if the covered entity informs the individual in writing of 
the reasons it requires more time and when the request will be granted.  § 164.524(b)(2)(iii). 
 160. § 164.524(c)(2)(ii). 
 161. § 164.524(a)(1), (2).  Information obtained from another based on a promise of 
confidentiality and that would likely reveal the identity of the source may be denied without 
review.  § 164.524(a)(2)(v).  Also, health care providers may temporarily deny access during 
research based on an individual’s care if the individual has consented to the research, and the 
denial of access occurs during research.  § 164.524(a)(2)(iii). 
 162. These situations include where a licensed health care professional determines that access 
will endanger the life or physical safety of the individual or another person.  § 164.524(c)(3). 
 163. Id.  This provision specifically covers determinations that references to another person 
will endanger that other individual, or that, if a personal representative is making the request, 
substantial harm will come to the individual or another person.  § 164.524(c)(3). 
 164. The denial must be in writing and in plain language.  It must explain the reasons for the 
denial, any rights for review over the decision and methods of complaint to the covered entity.  § 
164.524(d)(2).  Access should be granted to any information that does not meet the specific 
grounds for denial.  § 164.524(d)(1).  If a review of the denial is warranted, it is conducted by a 
licensed health care professional who is designated by the covered entity but is not directly 
involved in the decision to deny access.  § 164.524(d)(4). 
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3. Amend Protected Health Information 
Individuals may amend their PHI if they note inaccuracies or missing 
information.165  The covered entity must act within sixty days on a request to 
amend.166  If the covered entity agrees to the amendment, it must (a) identify 
the records that are affected by the amendment, (b) append or provide a link to 
the amendment167 and (c) inform the individual of the amendment.168  
Additional covered entities who possess or receive the data must amend their 
records with the corrected information about the relevant individual.169  As 
with access rights, covered entities may deny amendments in certain 
circumstances, including upon a determination that the record is “accurate and 
complete.”170  The entity must give written notice to the individual upon denial 
of a request for an amendment.171  Should the individual disagree in writing,172 
the covered entity can respond with a written rebuttal.173  Yet, unlike disputes 
over denial to access, there is no final review to clarify which party, the 





 165. § 164.526(a)(1).  See Gostin, Health Information Privacy, supra note 4, at 524 and 
HEALTH PRIVACY PROJECT, BEST PRINCIPLES, supra note 72, at 18-19, for more on the 
significance of this right. 
 166. § 164.526(b)(2)(i).  An extension of thirty days is possible if the covered entity explains 
the reasons for delay and the date on which it will respond to the request in writing to the 
individual.  § 164.526(b)(2)(ii). 
 167. § 164.526(c)(1), (2). 
 168. § 164.526(c)(2), (3).  It must also notify persons or entities (1) identified by the 
individual as needing the amended information; or (2) known by the covered entity to have PHI 
about the individual and who may rely on the information to the detriment of the individual.  Id. 
 169. § 164.526(e). 
 170. § 164.526(a)(2)(iv).  Other grounds for denial are: (1) if the covered entity did not create 
the information or record, it may deny the request unless the individual reasonably shows that the 
originator of the information is no longer available to address the amendment request and (2) if 
the individual could not access the record because of restrictions laid out in § 164.524 (see Part 
II.D.1 above), the covered entity would have grounds to deny the amendment.  § 164.526(a)(2)(i), 
(iii). 
 171. § 164.526(d)(1).  It must be in plain language and explain the reasons for the denial, any 
rights for review over the decision and methods of complaint to the covered entity.  § 
164.526(d)(1)(i)-(iv). 
 172. § 164.526(d)(2). 
 173. § 164.526(d)(3).  The individual must be provided with a copy of the rebuttal.  The 
written statement and rebuttal must then be appended or linked to the appropriate records by the 
covered entity (§ 164.526(d)(4)) and included, when relevant, in any future disclosures.  § 
164.526(d)(5)(i).  If the individual has not submitted a written statement of disagreement, then the 
request for amendment and covered entity’s denial must be included if the individual has 
requested such disclosure.  § 164.526(d)(5)(ii). 
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4. Request an Accounting of Disclosures 
Patients have a limited right to receive an accounting of disclosures of their 
PHI (other than for disclosures related to treatment, payment and health care 
operations, among other exceptions174) over the six year period prior to the 
request.175  The accounting includes the name of the person or entity who 
received the information (and their address if known), the date of the 
disclosure, a brief description of the information disclosed and a brief 
explanation of the reasons for disclosure if not authorized by the patient.176 
E. The Effects of Pre-emption 
Under HIPAA, HHS cannot preempt state health information privacy laws 
that are more protective of patients than the national rule.177  For this reason, 
the rule sets a federal “floor” of protections.  Some states may offer more 
protections through, for example, “super-confidentiality” laws for genetic, 
mental health or HIV/AIDS information.178  This multi-level approach to 
protecting privacy has at least two disadvantages: (1) it unfairly allows 
individuals in some states to benefit from greater privacy protections than in 
other states; and (2) where most electronic health data is exchanged across 
state boundaries, covered entities (specifically larger health providers, plans 
and clearinghouses) must adhere to both national and regional privacy 
standards.  This likely results in higher costs than would occur if a uniform 
national standard was in place.179 
III.  CONCLUSION 
The systematic electronic collection, use and disclosure of individually-
identifiable health information are essential to achieving several important 
communal goals.  Public health authorities and health researchers require such 
data to perform accurate, beneficial studies and to shape effective interventions 
and treatments.  The exchange of electronic data can improve clinical 
outcomes, prevent fraud and abuse, and help consumers make informed 
choices about their health care.  With these positive aspects, however, come 
significant threats to individual privacy.  People are concerned about 
 
 174. These include: national security and intelligence purposes; correctional institutions; and 
health oversight agencies or law enforcement officials who document that the agency’s officials 
would be impeded if the accounting revealed the disclosure.  § 164.528(a)(1), (2). 
 175. § 164.528(a)(1). 
 176. § 164.528(b)(2)(i)-(iv). 
 177. § 160.203(b).  State laws are also not pre-empted if they promote certain goods such as 
public health, efficacy in payment of health care, fraud prevention and audits and program 
monitoring.  § 160.203(a)(1)(i), (iv), (d). 
 178. See Gostin, Regulations under HIPAA, supra note 86, at 3020. 
 179. See id. 
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discrimination and autonomy violations that follow unwarranted disclosures to 
health insurers, employers and governmental agencies. 
Through its health information privacy rule, HHS seeks to provide a 
national standard that balances individual interests in health information 
privacy with society’s interests in accomplishing various communal goals.  
The rule provides expansive, new protections for health data privacy and 
security.  In many ways it improves existing privacy protections by creating a 
more fair and even field in which information can be responsibly exchanged.  
Unfortunately, the rule fails to provide a sufficient floor of protection for the 
use and disclosure of all health information.  Limited by Congressional 
authorization under HIPAA, HHS at times trades personal privacy for public 
(such as the public health exception) and non-public goods (such as the 
commercial marketing exception).  Reaching a proper balance between 
individual and communal uses of health data may require additional 
authorization from Congress, or alternatively, new federal legislation.  For 
now, the rule represents a new standard in an age of increasing threats to 
individual interests in protecting the privacy of their health data. 
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